20197-76-6

Basic information

• Product Name: 7-AMINO-2,3-DIHYDRO-BENZO[1,4]DIOXINE-6-CARBOXYLIC ACID METHYL ESTER
• Synonyms: 7-AMINO-2,3-DIHYDRO-BENZO[1,4]DIOXINE-6-CARBOXYLIC ACID METHYL ESTER;Methyl7-amino-2,3-dihydrobenzo[b][1,4]dioxine-6-carboxylate
• CAS NO: 20197-76-6
• Molecular Formula: C₁₀H₁₁NO₄
• Molecular Weight: 209.2
• Mol File: 20197-76-6.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 354.5±42.0 °C(Predicted)
• Appearance: /
• Density: 1.319±0.06 g/cm3(Predicted)
• PKA: 2.71±0.20(Predicted)
• CAS DataBase Reference: 7-AMINO-2,3-DIHYDRO-BENZO[1,4]DIOXINE-6-CARBOXYLIC ACID METHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 7-AMINO-2,3-DIHYDRO-BENZO[1,4]DIOXINE-6-CARBOXYLIC ACID METHYL ESTER(20197-76-6)
• EPA Substance Registry System: 7-AMINO-2,3-DIHYDRO-BENZO[1,4]DIOXINE-6-CARBOXYLIC ACID METHYL ESTER(20197-76-6)

Safety Data

• Hazard Codes: Xi
• HazardClass: IRRITANT
• Hazardous Substances Data: 20197-76-6(Hazardous Substances Data)

Upstream product

• 52791-03-4 7-nitro-2,3-dihydro-benzo[1,4]dioxine-6-carboxylic acid methyl ester 
• 20197-75-5 2,3-dihydro-benzo[1,4]dioxine-6-carboxylic acid methyl ester 
• 2150-43-8 3,4-dihydroxybenzoic acid methyl ester 
• 4442-54-0 2,3-dihydro-1,4-benzodioxin-6-carboxylic acid 
• 99-50-3 3,4-Dihydroxybenzoic acid 

Downstream Products

• 52791-04-5 3,4,7,8-tetrahydro[1,4]dioxino[2,3-g]quinazolin-4-one 
• 99358-09-5 7-amino-2,3-dihydrobenzo[b][1,4]dioxine-6-carboxylic acid 

Relevant articles and documents

BENZOXAZINONE COMPOUNDS AS KLK5/7 DUAL INHIBITORS

The present invention provides compounds and pharmaceutical compositions including the compounds for the treatment of a skin disease associated with proteolytic activity of one or more KLK proteases, wherein the compounds are according to formula (I): whe

METHODS AND COMPOUNDS FOR ANTIMICROBIAL INTERVENTION

The present invention provides Wall Teichoic Acid biosynthesis inhibitors such as compound 1835F03 (targocil) and related synthetic analogs. The invention also provides pharmaceutical compositions thereof and methods for treating bacterial infection and t

Preparation of 3-cyanoquinolines as protein tyrosine kinase inhibitors.

-